enGene (ENGNW) Expected to Announce Earnings on Friday

enGene (NASDAQ:ENGNW) is projected to announce its resultson Friday, June 12th. Analysts expect the company to announce earnings of ($0.4662) per share for the quarter.

enGene Trading Down 17.8%

Shares of NASDAQ:ENGNW opened at $0.23 on Friday. The company has a 50 day moving average of $1.42 and a 200-day moving average of $2.38. enGene has a one year low of $0.11 and a one year high of $4.20.

About enGene

enGene Holdings Inc, through its subsidiary enGene, Inc, operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.